The Value Forge
Primary Study
-
Primary Study
NEW
Ceftriaxone use for community bloodstream infections is associated with tripled thirty-day mortality
A meta-analysis of eleven studies found ceftriaxone use for MSSA bloodstream infections associated with OR 3.33 for 30-day mortality compared with anti-staphylococcal penicillins or cefazolin.
